As per this agreement, Alector obtained $700m in upfront and qualified for up to an additional $1.5bn in milestone payments. Alector CEO Arnon Rosenthal said: “In partnership with GSK ...

In a challenging market environment, Alector Inc (NASDAQ:ALEC) stock has touched a 52-week low, sinking to $1.59. With a market capitalization of $158.65 million, InvestingPro analysis suggests ...

Last year, Alector reported phase 1 results with AL003 in healthy volunteers and Alzheimer's patients at the Clinical Trials on Alzheimer's Disease (CTAD) conference, showing it was well tolerated ...